Copyright Reports & Markets. All rights reserved.

Global Standard Lancets Market Research Report 2021

Request for Sample of this report
Buy now

1 Standard Lancets Market Overview

  • 1.1 Product Overview and Scope of Standard Lancets
  • 1.2 Standard Lancets Segment by Type
    • 1.2.1 Global Standard Lancets Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Needle
    • 1.2.3 Blade
  • 1.3 Standard Lancets Segment by Application
    • 1.3.1 Standard Lancets Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospitals and Clinics
    • 1.3.3 Homecare Settings
    • 1.3.4 Others
  • 1.4 Global Standard Lancets Market Size Estimates and Forecasts
    • 1.4.1 Global Standard Lancets Revenue 2016-2027
    • 1.4.2 Global Standard Lancets Sales 2016-2027
    • 1.4.3 Standard Lancets Market Size by Region: 2016 Versus 2021 Versus 2027

2 Standard Lancets Market Competition by Manufacturers

  • 2.1 Global Standard Lancets Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Standard Lancets Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Standard Lancets Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Standard Lancets Manufacturing Sites, Area Served, Product Type
  • 2.5 Standard Lancets Market Competitive Situation and Trends
    • 2.5.1 Standard Lancets Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Standard Lancets Players Market Share by Revenue
    • 2.5.3 Global Standard Lancets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Standard Lancets Retrospective Market Scenario by Region

  • 3.1 Global Standard Lancets Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Standard Lancets Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Standard Lancets Market Facts & Figures by Country
    • 3.3.1 North America Standard Lancets Sales by Country
    • 3.3.2 North America Standard Lancets Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Standard Lancets Market Facts & Figures by Country
    • 3.4.1 Europe Standard Lancets Sales by Country
    • 3.4.2 Europe Standard Lancets Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Standard Lancets Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Standard Lancets Sales by Region
    • 3.5.2 Asia Pacific Standard Lancets Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Standard Lancets Market Facts & Figures by Country
    • 3.6.1 Latin America Standard Lancets Sales by Country
    • 3.6.2 Latin America Standard Lancets Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Standard Lancets Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Standard Lancets Sales by Country
    • 3.7.2 Middle East and Africa Standard Lancets Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Standard Lancets Historic Market Analysis by Type

  • 4.1 Global Standard Lancets Sales Market Share by Type (2016-2021)
  • 4.2 Global Standard Lancets Revenue Market Share by Type (2016-2021)
  • 4.3 Global Standard Lancets Price by Type (2016-2021)

5 Global Standard Lancets Historic Market Analysis by Application

  • 5.1 Global Standard Lancets Sales Market Share by Application (2016-2021)
  • 5.2 Global Standard Lancets Revenue Market Share by Application (2016-2021)
  • 5.3 Global Standard Lancets Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Roche
    • 6.1.1 Roche Corporation Information
    • 6.1.2 Roche Description and Business Overview
    • 6.1.3 Roche Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Roche Product Portfolio
    • 6.1.5 Roche Recent Developments/Updates
  • 6.2 Lifescan
    • 6.2.1 Lifescan Corporation Information
    • 6.2.2 Lifescan Description and Business Overview
    • 6.2.3 Lifescan Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Lifescan Product Portfolio
    • 6.2.5 Lifescan Recent Developments/Updates
  • 6.3 BD
    • 6.3.1 BD Corporation Information
    • 6.3.2 BD Description and Business Overview
    • 6.3.3 BD Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 BD Product Portfolio
    • 6.3.5 BD Recent Developments/Updates
  • 6.4 Bayer
    • 6.4.1 Bayer Corporation Information
    • 6.4.2 Bayer Description and Business Overview
    • 6.4.3 Bayer Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Bayer Product Portfolio
    • 6.4.5 Bayer Recent Developments/Updates
  • 6.5 Abbott
    • 6.5.1 Abbott Corporation Information
    • 6.5.2 Abbott Description and Business Overview
    • 6.5.3 Abbott Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Abbott Product Portfolio
    • 6.5.5 Abbott Recent Developments/Updates
  • 6.6 B. Braun
    • 6.6.1 B. Braun Corporation Information
    • 6.6.2 B. Braun Description and Business Overview
    • 6.6.3 B. Braun Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 B. Braun Product Portfolio
    • 6.6.5 B. Braun Recent Developments/Updates
  • 6.7 ARKRAY
    • 6.6.1 ARKRAY Corporation Information
    • 6.6.2 ARKRAY Description and Business Overview
    • 6.6.3 ARKRAY Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 ARKRAY Product Portfolio
    • 6.7.5 ARKRAY Recent Developments/Updates
  • 6.8 Terumo
    • 6.8.1 Terumo Corporation Information
    • 6.8.2 Terumo Description and Business Overview
    • 6.8.3 Terumo Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Terumo Product Portfolio
    • 6.8.5 Terumo Recent Developments/Updates
  • 6.9 I-SENS
    • 6.9.1 I-SENS Corporation Information
    • 6.9.2 I-SENS Description and Business Overview
    • 6.9.3 I-SENS Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 I-SENS Product Portfolio
    • 6.9.5 I-SENS Recent Developments/Updates
  • 6.10 Nipro
    • 6.10.1 Nipro Corporation Information
    • 6.10.2 Nipro Description and Business Overview
    • 6.10.3 Nipro Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Nipro Product Portfolio
    • 6.10.5 Nipro Recent Developments/Updates
  • 6.11 Omron
    • 6.11.1 Omron Corporation Information
    • 6.11.2 Omron Standard Lancets Description and Business Overview
    • 6.11.3 Omron Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Omron Product Portfolio
    • 6.11.5 Omron Recent Developments/Updates
  • 6.12 Infopia
    • 6.12.1 Infopia Corporation Information
    • 6.12.2 Infopia Standard Lancets Description and Business Overview
    • 6.12.3 Infopia Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Infopia Product Portfolio
    • 6.12.5 Infopia Recent Developments/Updates
  • 6.13 AgaMatrix
    • 6.13.1 AgaMatrix Corporation Information
    • 6.13.2 AgaMatrix Standard Lancets Description and Business Overview
    • 6.13.3 AgaMatrix Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 AgaMatrix Product Portfolio
    • 6.13.5 AgaMatrix Recent Developments/Updates
  • 6.14 Smiths Medical
    • 6.14.1 Smiths Medical Corporation Information
    • 6.14.2 Smiths Medical Standard Lancets Description and Business Overview
    • 6.14.3 Smiths Medical Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 Smiths Medical Product Portfolio
    • 6.14.5 Smiths Medical Recent Developments/Updates
  • 6.15 Sarstedt
    • 6.15.1 Sarstedt Corporation Information
    • 6.15.2 Sarstedt Standard Lancets Description and Business Overview
    • 6.15.3 Sarstedt Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
    • 6.15.4 Sarstedt Product Portfolio
    • 6.15.5 Sarstedt Recent Developments/Updates
  • 6.16 SANNUO
    • 6.16.1 SANNUO Corporation Information
    • 6.16.2 SANNUO Standard Lancets Description and Business Overview
    • 6.16.3 SANNUO Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
    • 6.16.4 SANNUO Product Portfolio
    • 6.16.5 SANNUO Recent Developments/Updates
  • 6.17 Yicheng
    • 6.17.1 Yicheng Corporation Information
    • 6.17.2 Yicheng Standard Lancets Description and Business Overview
    • 6.17.3 Yicheng Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
    • 6.17.4 Yicheng Product Portfolio
    • 6.17.5 Yicheng Recent Developments/Updates
  • 6.18 Yuwell
    • 6.18.1 Yuwell Corporation Information
    • 6.18.2 Yuwell Standard Lancets Description and Business Overview
    • 6.18.3 Yuwell Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
    • 6.18.4 Yuwell Product Portfolio
    • 6.18.5 Yuwell Recent Developments/Updates
  • 6.19 Greiner Bio One
    • 6.19.1 Greiner Bio One Corporation Information
    • 6.19.2 Greiner Bio One Standard Lancets Description and Business Overview
    • 6.19.3 Greiner Bio One Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
    • 6.19.4 Greiner Bio One Product Portfolio
    • 6.19.5 Greiner Bio One Recent Developments/Updates
  • 6.20 Edan
    • 6.20.1 Edan Corporation Information
    • 6.20.2 Edan Standard Lancets Description and Business Overview
    • 6.20.3 Edan Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
    • 6.20.4 Edan Product Portfolio
    • 6.20.5 Edan Recent Developments/Updates
  • 6.21 Narang Medical
    • 6.21.1 Narang Medical Corporation Information
    • 6.21.2 Narang Medical Standard Lancets Description and Business Overview
    • 6.21.3 Narang Medical Standard Lancets Sales, Revenue and Gross Margin (2016-2021)
    • 6.21.4 Narang Medical Product Portfolio
    • 6.21.5 Narang Medical Recent Developments/Updates

7 Standard Lancets Manufacturing Cost Analysis

  • 7.1 Standard Lancets Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Standard Lancets
  • 7.4 Standard Lancets Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Standard Lancets Distributors List
  • 8.3 Standard Lancets Customers

9 Standard Lancets Market Dynamics

  • 9.1 Standard Lancets Industry Trends
  • 9.2 Standard Lancets Growth Drivers
  • 9.3 Standard Lancets Market Challenges
  • 9.4 Standard Lancets Market Restraints

10 Global Market Forecast

  • 10.1 Standard Lancets Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Standard Lancets by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Standard Lancets by Type (2022-2027)
  • 10.2 Standard Lancets Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Standard Lancets by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Standard Lancets by Application (2022-2027)
  • 10.3 Standard Lancets Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Standard Lancets by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Standard Lancets by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Needle
    Blade

    Segment by Application
    Hospitals and Clinics
    Homecare Settings
    Others

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Roche
    Lifescan
    BD
    Bayer
    Abbott
    B. Braun
    ARKRAY
    Terumo
    I-SENS
    Nipro
    Omron
    Infopia
    AgaMatrix
    Smiths Medical
    Sarstedt
    SANNUO
    Yicheng
    Yuwell
    Greiner Bio One
    Edan
    Narang Medical

    Buy now